Evidence map›Paper›PMID 21605675›Full record

ArticleNeurobiology of disease2011

Presynaptic silencing is an endogenous neuroprotectant during excitotoxic insults.

Joshua Hogins, Devon C Crawford, Xiaoping Jiang, Steven Mennerick

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. GABAeLife · 2023
    Article
  4. Review
  5. Review
  6. Cell Clearing Systems Bridging Neuro-Immunity and Synaptic Plasticity.International journal of molecular sciences · 2019
    Review
  7. Article
  8. Loss of Doc2-Dependent Spontaneous Neurotransmission Augments Glutamatergic Synaptic Strength.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  9. 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2016
    Review
  10. Article
  11. Review
  12. Article
  13. Astrocyte-derived thrombospondins mediate the development of hippocampal presynaptic plasticity in vitro.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  14. Article
  15. Presynaptically silent synapses: dormancy and awakening of presynaptic vesicle release.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2012
    Review
  16. Synaptic NMDA receptors mediate hypoxic excitotoxic death.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joshua HoginsDept of Psychiatry, Washington University in St. Louis, 660 S. Euclid Ave., St. Louis, MO 63110, USA.
Devon C Crawford
Xiaoping Jiang
Steven Mennerick
Washington University in St. Louis · US

Funding

BIOMEDICAL RESEARCH TRAINING IN DRUG ABUSET32DA007261 · NIDA · WASHINGTON UNIVERSITY · PI ARPANA AGRAWAL, Jose A Moron-Concepcion · 1991 to 2026
$8.8M
CONTROL OF SYNAPTIC GLUTAMATE RELEASER01MH078823 · NIMH · WASHINGTON UNIVERSITY · PI MENNERICK, STEVEN J · 2006 to 2015
$3.2M
Axonal Signaling in the HippocampusR01NS054174 · NINDS · WASHINGTON UNIVERSITY · PI MENNERICK, STEVEN J · 2006 to 2010
$1.5M
Induction pathways in hippocampal adaptive synaptic plasticityF31NS066611 · NINDS · WASHINGTON UNIVERSITY · PI CRAWFORD, DEVON C · 2009 to 2010
$54k
NIDA NIH HHS DA07261NIDA NIH HHS T32 DA007261NIMH NIH HHS MH78823NIMH NIH HHS R01 MH078823NINDS NIH HHS F31 NS066611NINDS NIH HHS NS066611NINDS NIH HHS NS54174NINDS NIH HHS R01 NS054174
6 · The paper itself

Abstract

Glutamate release is a root cause of acute and delayed neuronal damage in response to hypoxic/ischemic insults. Nevertheless, therapeutics that target the postsynaptic compartment have been disappointing clinically. Here we explored whether presynaptic silencing (muting) of glutamatergic terminals is sufficient to reduce excitotoxic damage resulting from hypoxia and oxygen/glucose deprivation. Our evidence suggests that strong depolarization, previously shown to mute glutamate synapses, protects neurons by a presynaptic mechanism that is sensitive to inhibition of the proteasome. Postsynaptic Ca2+ rises in response to glutamate application and toxicity in response to exogenous glutamate treatment were unaffected by depolarization preconditioning. These features strongly suggest that reduced glutamate release explains preconditioning protection. We addressed whether hypoxic depolarization itself induces presynaptic silencing, thereby participating in the damage threshold for hypoxic insult. Indeed, we found that the hypoxic insult increased the percentage of mute glutamate synapses in a proteasome-dependent manner. Furthermore, proteasome inhibition exacerbated neuronal loss to mild hypoxia and prevented hypoxia-induced muting. In total our results suggest that presynaptic silencing is an endogenous neuroprotective mechanism that could be exploited to reduce damage from insults involving excess synaptic glutamate release.

Indexed as

AnimalsAnimals, NewbornCalcium SignalingCells, CulturedDisease Models, AnimalExcitatory Postsynaptic PotentialsFemaleGlutamic AcidHippocampusHypoxia-Ischemia, BrainIschemic PreconditioningMaleNeural InhibitionNeurotoxinsPresynaptic TerminalsProteasome Endopeptidase ComplexGlutamic AcidNeurotoxinsProteasome Endopeptidase ComplexProteasome Inhibitors

Identifiers

PMID21605675
PMCPMC3114267
OpenAlexW2071407910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.